ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,566Medicare Part D Prescriptions Filled, Including Refills

Rank: 113 out of 2680

$821K Total Retail Price of All Prescriptions

Rank: 101 out of 2680

508 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 508 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

0% of this provider’s 9,476 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
LEVOTHYROXINE SODIUM 550 401 1 4
SIMVASTATIN 421 329 2 1
FUROSEMIDE 354 307 3 7
AMLODIPINE BESYLATE 325 291 4 3
OMEPRAZOLE 296 253 5 2
LISINOPRIL 286 226 6 5
SERTRALINE HCL 264 193 7 23
CALCITONIN-SALMON 258 192 8 265
METOPROLOL TARTRATE 255 226 9 8
CRESTOR 206 174 10 15
PRAVASTATIN SODIUM 192 170 11 16
WARFARIN SODIUM 191 126 12 12
ATORVASTATIN CALCIUM 187 160 13 10
JANUVIA 184 162 14 34
POLYETHYLENE GLYCOL 3350 160 97 15 55
METOPROLOL SUCCINATE 152 145 16 11
CARVEDILOL 140 135 17 27
METFORMIN HCL 139 127 18 6
POTASSIUM CHLORIDE 138 133 19 29
GABAPENTIN 129 109 20 21
SPIRIVA 128 126 21 36
PANTOPRAZOLE SODIUM 125 121 22 44
NEXIUM 109 88 23 19
DONEPEZIL HCL 101 91 24 28
IPRATROPIUM-ALBUTEROL 101 83 24 110
NAMENDA 100 100 26 43
LOSARTAN POTASSIUM 97 97 27 18
DIVALPROEX SODIUM 95 69 28 90
LEVETIRACETAM 94 50 29 94
TAMSULOSIN HCL 94 58 29 25
BISOPROLOL FUMARATE 92 84 31 163
HYDROCHLOROTHIAZIDE 92 86 31 9
ATENOLOL 92 86 31 14
CITALOPRAM HBR 90 65 34 22
HYDROCODONE-ACETAMINOPHEN 88 80 S3 35 13
NATEGLINIDE 82 74 36 315
ADVAIR DISKUS 82 74 36 32
RAMIPRIL 70 70 38 49
CLONIDINE HCL 69 66 39 84
CIPROFLOXACIN HCL 68 63 40 85
DIOVAN 68 68 40 26
ALENDRONATE SODIUM 65 38 42 20
PRADAXA 63 63 43 203
DILANTIN 63 31 43 312
PHENYTOIN SODIUM EXTENDED 62 43 45 207
KLOR-CON 10 62 53 45 177
GLIMEPIRIDE 62 51 45 51
CLOPIDOGREL 60 56 48 30
FLUTICASONE PROPIONATE 60 55 48 38
FAMOTIDINE 59 48 50 65
FENOFIBRATE 59 58 50 77
CARBIDOPA-LEVODOPA 57 42 52 88
BUDESONIDE 56 40 53 299
ALBUTEROL SULFATE 55 40 54 97
ESCITALOPRAM OXALATE 55 49 54 82
LANTUS 55 38 54 70
FLUOXETINE HCL 53 45 57 76
ZETIA 52 38 58 69
ALLOPURINOL 51 51 59 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.